US2015105582A1PendingUtilityA1
Treprostinil production
Est. expiryJun 3, 2030(~3.9 yrs left)· nominal 20-yr term from priority
C07C 67/343C07B 2200/07C07C 45/29C07C 51/09Y02P20/55C07C 59/72C07C 45/61C07C 51/367C07C 45/00C07C 253/30C07C 45/64C07C 62/12C07F 7/1892C07C 51/00C07C 29/143C07C 29/42C07C 51/16
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is directed to a novel method for preparing a synthetic intermediates for treprostinil. Also described are methods of preparing treprostinil comprising utilizing novel intermediates described herein as well as novel intermediates useful for synthesis prostacyclin derivatives, such as treprostinil.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A process of preparing treprostinil or a pharmaceutically acceptable salt thereof, of the formula:
or pharmaceutically acceptable salts thereof, which comprises:
(a) derivatizing m-hydroxybenzaldehyde with an allyl halide, to form an oxyalkene-substituted benzaldehyde of formula:
(b) subjecting the substituted oxyalkene-substituted benzaldehyde to Claisen rearrangement to form the m-hydroxy-substituted benzaldehyde of formula:
(c) protecting the m-hydroxy-substituted benzaldehyde with a p-methoxybenzyl, to form a protected benzaldehyde of formula:
wherein R is p-methoxybenzyl
(d) reacting the protected benzaldehyde with a 5-oxy-substituted decan-1,2-yne of formula:
wherein P 1 is an alcohol protecting group, to yield the compound of formula:
wherein R and P 1 are defined above;
(e) oxidizing the resulting compound to a ketone compound of:
wherein R and P 1 are defined above;
(f) chirally reducing the ketone compound to a chiral alcohol compound of formula:
wherein R and P 1 are defined above;
(g) protecting the chiral alcohol compound to yield a compound of formula:
wherein R is defined above, and P 1 , for each occurrence is independently an alcohol protecting group;
(h) intra-molecularly cyclizing the resulting compound to obtain a tricyclic enone compound of formula:
wherein R is defined above, and P 1 , for each occurrence is independently an alcohol protecting group;
(i) hydrogenating the tricyclic enone to form a tricyclic hydroxyl compound of formula:
and
(j) converting the preceding compound into treprostinil or a pharmaceutically acceptable salt thereof.
2 . The process of claim 1 including the additional, final step of converting the treprostinil so formed to its sodium salt.Join the waitlist — get patent alerts
Track US2015105582A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.